Roger Charles Harrison
Keine laufenden Positionen mehr
Profil
Roger Charles Harrison worked as a Senior Vice President at BTG Ltd.
and as a Chief Business Officer at Algeta ASA. He holds a doctorate degree from The University of Manchester.
Ehemalige bekannte Positionen von Roger Charles Harrison
| Unternehmen | Position | Ende |
|---|---|---|
| BTG | Corporate Officer/Principal | - |
| ALGETA ASA | Corporate Officer/Principal | - |
Ausbildung von Roger Charles Harrison
| The University of Manchester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
